<DOC>
	<DOCNO>NCT00239317</DOCNO>
	<brief_summary>The purpose study determine whether Tamusulosin effective treatment low urinary tract syndrome male patient .</brief_summary>
	<brief_title>Tamsulosin Phase III Clinical Trial -Double-Blind , Placebo Controlled Study Male Patients With Lower Urinary Tract Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Urologic Diseases</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Patients urination disorder accompany apparent organic neurologic abnormality ( low urinary tract syndrome : LUTs ) . Patients urination disorder accompany apparent organic ( benign prostatic hyperplasia : BPH ) neurologic abnormality , active urinary tract infection , severe cardiovascular , hepatic and/or kidney complication .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>tamsulosin</keyword>
	<keyword>urinary tract disease</keyword>
	<keyword>male</keyword>
</DOC>